Consolidated Portfolio Review Corp
Position in ROIV — Roivant Sciences Ltd.
CIK 1972835
WOODBURY, NY
Position in ROIV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$9,786,396
+$2,126,515 QoQ
Shares Held
276,530
0.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#108
of 494 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Consolidated Portfolio Review Corp holds $9,786,396 across 1 Biotechnology name. ROIV ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
276,530 | $9,786,396 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,786,396 | 276,530 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,659,881 | 276,530 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,000,701 | 276,530 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||